ResMed Inc.
RMDResMed Inc. is a global leader in digital health and cloud-connected medical devices, specializing in the treatment of sleep-disordered breathing and chronic respiratory diseases.
Earnings
Next report
Jan 28, 2027 (in 3 months)Segments
Competitors
By market cap
By revenue growth
Profile
ResMed Inc. is a global leader in digital health and cloud-connected medical devices, specializing in the treatment of sleep-disordered breathing and chronic respiratory diseases. The company designs and manufactures innovative hardware and software solutions that facilitate home-based healthcare, improve patient adherence to therapy, and lower overall costs for healthcare systems. Its ecosystem integrates AI-powered digital health applications with life-support and ventilation devices to manage chronic conditions more effectively.
ResMed is a dominant global leader in the sleep apnea market with a significant first-mover advantage in cloud-connected medical devices and integrated digital health ecosystems.
FAQ
- What is ResMed Inc.'s market cap?
- ResMed Inc. (RMD) has a market capitalization of $35.6B and trades on NYSE.
- What is ResMed Inc.'s revenue and profitability?
- ResMed Inc. generated $5.7B in trailing twelve-month revenue with net income of $1.6B, representing a net margin of 27.8%. Gross margin stands at 61.1%, with free cash flow of $1.6B. The latest reported period is Q1 2027.
- Who are ResMed Inc.'s competitors?
- ResMed Inc.'s key competitors include Inspire Medical Systems, Philips, Vivos Therapeutics, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does ResMed Inc. partner with?
- ResMed Inc.'s notable partners include Baxter.
- What subsidiaries does ResMed Inc. have?
- ResMed Inc.'s subsidiaries include Brightree, MEDIFOX DAN, Noctrix Health, LLC, and others.
- Where is ResMed Inc. headquartered?
- ResMed Inc. is headquartered in United States of America and employs approximately 10,140 people. It has been publicly traded since 1995.
